Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.38) per share. This is a 67.52 percent increase over losses of $(1.17) per share from the same period last year. The company reported $2.50 million in sales this quarter. This is a 7.41 percent decrease over sales of $2.70 million the same period last year.
What Tesla’s 3-For-1 Split Means For The Battered Stock: ‘A Smart Move By Board’
Tesla, Inc. (NASDAQ: TSLA) finally filed a proxy statement with the SEC, wherein it revealed that it intends to implement a 3-for-1 split in the form of a stock dividend.
